NatureWise Biotech & Medicals Corporation (TPEX:4732)

TPEX:4732 Revenue

NatureWise Biotech & Medicals had revenue of 84.62M TWD in the half year ending June 30, 2026, a decrease of -35.30%. This brings the company's total for the last twelve months to 174.62M, down -3.15% year-over-year. In the year 2025, NatureWise Biotech & Medicals had annual revenue of 176.77M, down -21.20%. That makes NatureWise Biotech & Medicals the 39,730th largest company in the world by revenue and 2,054th in Taiwan.

• Revenue (ttm): 174.62M
• Revenue Growth: -3.15%
• P/S Ratio: 4.30
• Revenue / Employee: 5.46M
• Employees: 31
• Market Cap: 751.08M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 172.10M 97.4%
• Mainland China 4.50M 2.5%
• Other 166.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full TPEX:4732 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	176.77M	-47.56M	-21.20%
Dec 31, 2024	224.32M	64.18M	40.08%
Dec 31, 2023	160.14M	-68.45M	-29.94%
Dec 31, 2022	228.59M	-21.21M	-8.49%
Dec 31, 2021	249.80M	-57.12M	-18.61%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 28, 2026

Data Sources Report a data error